Beyond Recognition: A Three-Dimensional Analytical Framework for Tumor-Immune Control Failure
Beyond Tumor Recognition: A Three-Dimensional Framework for Understanding Tumor–Immune Control Failure and Therapeutic InterventionThis research proposes a three-dimensional conceptual framework for understanding why effective tumor–immune control may fail, extending the analysis beyond tumor recognition alone.The framework integrates three interacting dimensions:Immune Compatibility: The degree of compatibility between tumor characteristics and the host immune system, including tumor-side antigen presentation and host-side immune competence.Immune Execution Efficiency: The ability of immune effectors to reach tumor cells, penetrate tumor tissue, engage their targets, and execute effective antitumor functions.Dynamic Adaptation: The reciprocal evolution of tumor populations and immune responses over time, including immune escape, clonal selection, and changes in tumor susceptibility.The tumor microenvironment is considered a cross-cutting modifier influencing all three dimensions through vascular, stromal, metabolic, and immunosuppressive mechanisms.The framework further introduces a proposed bottleneck-prioritization approach to identify potentially rate-limiting constraints on tumor–immune control and guide the development of mechanism-matched research strategies.This work is a hypothesis-generating conceptual framework, not a clinically validated model or treatment algorithm. Its proposed scientific contribution requires further experimental and prospective validation.Author: Mohammed Fuad Yousef AbuamraResearch Status: Conceptual Framework – Version 1.1Research Area: Cancer Biology, Tumor Immunology, Systems Oncology, and Translational Research.
Authors
- Mohammed Fuad Yousef Abuamra (ORCID: https://orcid.org/0009-0005-3183-9401)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-12
- DOI
- https://doi.org/10.5281/zenodo.24163288
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- preprint